DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 105.92 USD -1.48% Market Closed
Market Cap: $7.5B

Net Margin

5.8%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.8%
=
Net Income
$771.9m
/
Revenue
$13.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
5.8%
=
Net Income
$771.9m
/
Revenue
$13.3B

Peer Comparison

Country Company Market Cap Net
Margin
US
DaVita Inc
NYSE:DVA
7.5B USD
Loading...
US
CVS Health Corp
NYSE:CVS
90.2B USD
Loading...
US
Cigna Group
XMUN:CGN
60.5B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.1B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.9B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.3B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.4B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.3B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
57th
Based on 15 072 companies
57th percentile
5.8%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

DaVita Inc
Glance View

In the intricate network of healthcare services, DaVita Inc. stands as a pivotal player, focusing on the often-overlooked but critical field of kidney care. Rooted in its mission to improve patients' quality of life by innovating kidney care therapies, DaVita has cultivated a robust operation primarily revolving around dialysis services. Chronic Kidney Disease (CKD) and kidney failure are rising global health concerns, necessitating regular dialysis treatments for affected individuals. DaVita serves this need through a network of dialysis centers, offering both in-center and at-home dialysis options. By prioritizing patient comfort and convenience alongside medical efficiency, DaVita has positioned itself as a go-to choice for those requiring ongoing renal care, effectively making the process as seamless as possible for patients. The business model of DaVita hinges on its ability to deliver consistent, high-quality care while managing costs—a balance crucial to success in the healthcare industry. Revenue flows in from both governmental programs such as Medicare and private health insurers, which fund the dialysis treatments for insured patients. DaVita's strategic strength lies in its operational scale, with a vast number of outpatient dialysis centers across the U.S. and internationally. This extensive reach not only strengthens its market position but also provides a wealth of data and feedback, fueling further innovation and efficiency improvements. By leveraging this extensive network, DaVita continues to tap into the growing demand for accessible, comprehensive kidney care services, reinforcing its commitment to patient-centered healthcare delivery while sustaining its financial growth.

DVA Intrinsic Value
245.77 USD
Undervaluation 57%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
5.8%
=
Net Income
$771.9m
/
Revenue
$13.3B
What is DaVita Inc's current Net Margin?

The current Net Margin for DaVita Inc is 5.8%, which is in line with its 3-year median of 5.8%.

How has Net Margin changed over time?

Over the last 3 years, DaVita Inc’s Net Margin has decreased from 5.8% to 5.8%. During this period, it reached a low of 4% on Jun 30, 2023 and a high of 7.3% on Dec 31, 2024.

Back to Top